Skip to main content
Clinical Trials/NCT03717766
NCT03717766
Unknown
Not Applicable

Application of New Technologies in the Resection of Intracranial Tumors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau0 sites100 target enrollmentOctober 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intracranial Neoplasm
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Enrollment
100
Primary Endpoint
Percentage of intracranial tumor resection
Last Updated
7 years ago

Overview

Brief Summary

Main Outcome: To assess the effectiveness of new intraoperative technologies in the resection of intracranial tumors.

Design: Prospective observational study.

Method: Prospective observational study of the use and effectiveness of intraoperative neuronavigation ultrasound, intraoperative tractography, intraoperative fluorescence, advanced neuronavigation and intraoperative neurophysiology in the resection of intracranial supratentorial tumors.

Number of patients: 70 - 100.

Duration of the study: 3 years.

Ethical considerations: The study will be carried out following the international ethical recommendations for medical research in humans. Before beginning the study, the Ethical Committee of the Hospital of Santa Creu i Sant Pau approved the study protocol. It is about the study of surgical techniques that we use in our usual clinical practice.

Fundings: There are no funding sources.

Registry
clinicaltrials.gov
Start Date
October 2018
End Date
September 2020
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • intraaxial brain tumors that are tributary to surgical treatment.

Exclusion Criteria

  • extra-axial brain tumors.

Outcomes

Primary Outcomes

Percentage of intracranial tumor resection

Time Frame: 3 years

Effectiveness of new intraoperative technologies in the resection of intracranial tumors in terms of percentage of intracranial tumor resection and neurological deficit

Similar Trials